INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of HCA Healthcare, Inc. - HCA

NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact Danielle Peyton at  newaction@pomlaw.com  or 646-581-9980, ext.

PRNewsWire • 10 hours ago

More Than 100 HCA Healthcare Hospitals Recognized by Healthgrades for Excellence in Specialty Care

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that 102 of its hospitals have been recognized by Healthgrades for excellence in specialty care, more than any other health system in the country. The 2027 recognitions reflect clinical outcomes in important areas of patient care, including surgical care, emergency medicine and orthopedic surgery. For patients and families making healthcare decisions, these recog.

Business Wire • 11 hours ago

HCA Healthcare Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Results

HCA Healthcare Inc. (NYSE:HCA) on Tuesday posted upbeat third-quarter results.

Benzinga • Oct 28, 2026

HCA Healthcare: Payer Mix Pressures, But Broad Trends On Track

HCA Healthcare, Inc. is reiterated at Hold, with shares trading near fair value and a mixed technical outlook. Q3 results beat expectations: non-GAAP EPS of $7.22 and revenue of $19.9B, driven by strong volume growth and the Virginia SDP program impact. Management raised FY guidance to the upper half of prior range, but ongoing payer mix pressures and Medicaid headwinds persist.

Seeking Alpha • Oct 28, 2026

HCA Healthcare Beats Wall Street Estimates, But $400 Million Coverage Gap Trips the Stock

U.S.-based hospital HCA Healthcare Inc. (NYSE:HCA) released third-quarter 2026 revenues of $19.849 billion, representing a 3.6% year-over-year increase, beating the consensus estimate of $19.332 billion.

Benzinga • Oct 27, 2026

HCA Healthcare Stock Nears Buy Point Despite Uninsured Cost Jump

The jump in uninsured patient costs sliced $400 million from pre-tax earnings.

Investors Business Daily • Oct 27, 2026

What HCA Healthcare (HCA) Said on Its Q3 Earnings Call

HCA Healthcare NYSE: HCA said third-quarter results modestly exceeded its expectations as admissions growth, improved insured revenue per admission and disciplined cost management helped offset pressure from patients losing health insurance exchange coverage.

MarketBeat • Oct 27, 2026

HCA Healthcare Profit Slips but Revenue Rises

The operator of healthcare facilities on posted net income of $1.58 billion, compared with $1.64 billion in the same quarter a year ago.

WSJ • Oct 27, 2026

HCA Healthcare, Inc. (HCA) Q3 2026 Earnings Call Transcript

HCA Healthcare, Inc. ( HCA ) Q3 2026 Earnings Call October 27, 2026 10:00 AM EDT Company Participants Frank Morgan - Vice President of Investor Relations Samuel Hazen - CEO & Director Mike Marks - CFO & Executive VP Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies LLC, Research Division Pito Chickering - Deutsche Bank AG, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Sean Dodge - BMO Capital Markets Equity Research Benjamin Mayo - Leerink Partners LLC, Research Division Ryan Langston - TD Cowen, Research Division Sarah James - Cantor Fitzgerald & Co., Research Division Justin Lake - Wolfe Research, LLC Kevin Fischbeck - BofA Securities, Research Division Scott Fidel - Goldman Sachs Group, Inc., Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Jason Cassorla - Guggenheim Securities, LLC, Research Division Raj Kumar - Stephens Inc., Research Division Benjamin Rossi - JPMorgan Chase & Co, Research Division Andrew Mok - Barclays Bank PLC, Research Division Craig Hettenbach - Morgan Stanley, Research Division Presentation Operator Welcome to the HCA Healthcare Third Quarter 2026 Earnings Conference Call. Today's call is being recorded.

Seeking Alpha • Oct 27, 2026

HCA Healthcare Reports Third Quarter 2026 Results

NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the third quarter ended September 30, 2026. Key third quarter metrics (all percentage changes compare 3Q 2026 to 3Q 2025 unless otherwise noted): Revenues increased 3.6 percent to $19.849 billion Net income attributable to HCA Healthcare, Inc. declined 3.9 percent to $1.579 billion Diluted earnings per share increased 4.5 percent to $7.27 per diluted share, and diluted earning.

Business Wire • Oct 27, 2026